These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9160523)

  • 21. Expression and purification of an immunogenic dengue virus epitope using a synthetic consensus sequence of envelope domain III and Saccharomyces cerevisiae.
    Nguyen NL; Kim JM; Park JA; Park SM; Jang YS; Yang MS; Kim DH
    Protein Expr Purif; 2013 Apr; 88(2):235-42. PubMed ID: 23376461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dengue 2 virus envelope protein expressed by a recombinant vaccinia virus fails to protect monkeys against dengue.
    Deubel V; Kinney RM; Esposito JJ; Cropp CB; Vorndam AV; Monath TP; Trent DW
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():1921-9. PubMed ID: 3404119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A plasmid encoding parts of the dengue virus E and NS1 proteins induces an immune response in a mouse model.
    Mellado-Sánchez G; García-Machorro J; Sandoval-Montes C; Gutiérrez-Castañeda B; Rojo-Domínguez A; García-Cordero J; Santos-Argumedo L; Cedillo-Barrón L
    Arch Virol; 2010 Jun; 155(6):847-56. PubMed ID: 20390312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preliminary evaluation of DNA vaccine candidates encoding dengue-2 prM/E and NS1: their immunity and protective efficacy in mice.
    Lu H; Xu XF; Gao N; Fan DY; Wang J; An J
    Mol Immunol; 2013 Jun; 54(2):109-14. PubMed ID: 23270684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of dengue 2 envelope domain III in plant using TMV-based vector system.
    Saejung W; Fujiyama K; Takasaki T; Ito M; Hori K; Malasit P; Watanabe Y; Kurane I; Seki T
    Vaccine; 2007 Sep; 25(36):6646-54. PubMed ID: 17659815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A DNA vaccine candidate encoding the structural prM/E proteins elicits a strong immune response and protects mice against dengue-4 virus infection.
    Lima DM; de Paula SO; França RF; Palma PV; Morais FR; Gomes-Ruiz AC; de Aquino MT; da Fonseca BA
    Vaccine; 2011 Jan; 29(4):831-8. PubMed ID: 21115054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression in Pichia pastoris and immunological evaluation of a truncated Dengue envelope protein.
    Valdés I; Hermida L; Zulueta A; Martín J; Silva R; Alvarez M; Guzmán MG; Guillén G
    Mol Biotechnol; 2007 Jan; 35(1):23-30. PubMed ID: 17401146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of a DNA vaccine candidate expressing prM-E-NS1 antigens of dengue virus serotype 1 with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) in immunogenicity and protection.
    Zheng Q; Fan D; Gao N; Chen H; Wang J; Ming Y; Li J; An J
    Vaccine; 2011 Jan; 29(4):763-71. PubMed ID: 21095256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inoculation of plasmids encoding Japanese encephalitis virus PrM-E proteins with colloidal gold elicits a protective immune response in BALB/c mice.
    Zhao Z; Wakita T; Yasui K
    J Virol; 2003 Apr; 77(7):4248-60. PubMed ID: 12634382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carboxy-terminally truncated Dengue 4 virus envelope glycoprotein expressed in Pichia pastoris induced neutralizing antibodies and resistance to Dengue 4 virus challenge in mice.
    Muné M; Rodríguez R; Ramírez R; Soto Y; Sierra B; Rodríguez Roche R; Marquez G; Garcia J; Guillén G; Guzmán MG
    Arch Virol; 2003 Nov; 148(11):2267-73. PubMed ID: 14579183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A DNA vaccine candidate expressing dengue-3 virus prM and E proteins elicits neutralizing antibodies and protects mice against lethal challenge.
    De Paula SO; Lima DM; de Oliveira França RF; Gomes-Ruiz AC; da Fonseca BA
    Arch Virol; 2008; 153(12):2215-23. PubMed ID: 19002647
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunogenicity of a Candidate DNA Vaccine Based on the prM/E Genes of a Dengue Type 2 Virus Cosmopolitan Genotype Strain.
    Putri DH; Sudiro TM; Yunita R; Jaya UA; Dewi BE; Sjatha F; Konishi E; Hotta H; Sudarmono P
    Jpn J Infect Dis; 2015; 68(5):357-63. PubMed ID: 25766602
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A DNA immunization model study with constructs expressing the tick-borne encephalitis virus envelope protein E in different physical forms.
    Aberle JH; Aberle SW; Allison SL; Stiasny K; Ecker M; Mandl CW; Berger R; Heinz FX
    J Immunol; 1999 Dec; 163(12):6756-61. PubMed ID: 10586074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of enhancing-activity-free neutralizing antibody against dengue type 1 virus in plasmid-inoculated mice.
    Yamanaka A; Pitaksajjakul P; Ramasoota P; Konishi E
    Vaccine; 2015 Nov; 33(45):6070-7. PubMed ID: 26259543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization of rhesus monkeys with a recombinant of modified vaccinia virus Ankara expressing a truncated envelope glycoprotein of dengue type 2 virus induced resistance to dengue type 2 virus challenge.
    Men R; Wyatt L; Tokimatsu I; Arakaki S; Shameem G; Elkins R; Chanock R; Moss B; Lai CJ
    Vaccine; 2000 Jul; 18(27):3113-22. PubMed ID: 10856791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A chimeric tetravalent dengue DNA vaccine elicits neutralizing antibody to all four virus serotypes in rhesus macaques.
    Raviprakash K; Apt D; Brinkman A; Skinner C; Yang S; Dawes G; Ewing D; Wu SJ; Bass S; Punnonen J; Porter K
    Virology; 2006 Sep; 353(1):166-73. PubMed ID: 16814355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies.
    Poddar A; Ramasamy V; Shukla R; Rajpoot RK; Arora U; Jain SK; Swaminathan S; Khanna N
    BMC Biotechnol; 2016 Jun; 16(1):50. PubMed ID: 27301568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis.
    Zhang YM; Hayes EP; McCarty TC; Dubois DR; Summers PL; Eckels KH; Chanock RM; Lai CJ
    J Virol; 1988 Aug; 62(8):3027-31. PubMed ID: 2969058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dengue 2 PreM-E/LAMP chimera targeted to the MHC class II compartment elicits long-lasting neutralizing antibodies.
    Lu Y; Raviprakash K; Leao IC; Chikhlikar PR; Ewing D; Anwar A; Chougnet C; Murphy G; Hayes CG; August TJ; Marques ET
    Vaccine; 2003 May; 21(17-18):2178-89. PubMed ID: 12706709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.